Leader in innovation

Therapeutic innovations

Innovation first and foremost

Théa, a company that focuses on its R&D

Pioneer and leader in eye care

For over 30 years, Théa has placed innovation at the heart of its mission in eye care.
Our growth strategy is built on:

  • Innovative and unique drug delivery systems
  • New active ingredients dedicated to eye health
  • Continuous improvement of existing formulations through advanced pharmaceutical research

With more than 30 major breakthroughs in 30 years, we have transformed the treatment of key eye diseases such as glaucoma, dry eye, ocular allergies, inflammation, and eye infections.

Théa has pioneered many world-first innovations in eye care, including:

  • Preservative-free eye drops
  • Eyelid hygiene solutions
  • Ocular nutrition supplements
  • Short-course antibiotic therapies
  • Trehalose-based treatments for dry eye disease

Today, Théa offers one of the most advanced ranges of ophthalmic products worldwide, combining therapeutic and technological innovation. Our solutions support eye care professionals and contribute to improving vision health for patients across the globe.

Consult all our areas of expertise
Formulation and "preservative-free" solutions

Innovative eye treatments and delivery systems

Tailored eye care solutions for every patient 

Specialized in eye care, we innovate in formulation and administration methods. Our wide range of products (single-dose eye drops, ointments, gels, injectables, etc.) addresses the specific needs of each patient.

Théa is also a pioneer in preservative-free forms and is the originator of the first multi-dose bottle capable of dispensing preservative-free eye drops: the ABAK®, with one bottle being distributed every second worldwide. 

Learn more about “preservative-free” solutions
Collaborating with the best

Collaborating with the best

The Théa group is 100% dedicated to eye care and offers a unique approach based on collaboration. 
While its R&D is carried out by a highly specialized internal team, Théa relies on an ecosystem of expert partners in their fields:

  • Strong partnerships: We collaborate with renowned institutions and support researchers in their projects.
     
  • 100% Made in Europe: Our products are manufactured exclusively at state-of-the-art production sites in Europe, with 60% located in France, following the highest pharmaceutical standards and regulations.
     
  • Local and international economic impact: These long-term collaborations create numerous jobs for our partners.

Théa benefits from global expertise and accelerates the development of new treatments. Our collaborative model, combined with high-quality production, makes Théa a major player in ocular health innovation.

Théa Open Innovation, a structure dedicated to open innovation

Théa Open Innovation, a structure dedicated to open innovation

Founded in 2019 by Jean-Frédéric Chibret, Théa Open Innovation (TOI) is a Théa business unit, designed to implement innovative solutions in ocular health. 

TOI’s mission is to:

  • Attract external expertise.
     
  • Establish new collaborations.
     
  • Foster the emergence of innovative solutions for the treatment of ocular diseases.

In practice, Théa Open Innovation continually fuels Théa's R&D branch with new projects, particularly in rare diseases and e-health solutions.

Learn more about Théa Open Innovation